Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis
Authors:
- 4 March 2014
- book chapter
- Published by Springer Nature
- Vol. 20, 75-97
Abstract
The neuropathic pain of multiple sclerosis is quite prevalent and severely impacts quality of life. A few randomized, placebo-controlled, blinded clinical trials suggest that cannabis- and anticonvulsant-based treatments provide partial pain relief, but at the expense of adverse events. An even smaller, but emerging, number of translational studies are using rodent models of experimental autoimmune encephalomyelitis (EAE), which exhibit pain-like behaviors resembling those of Multiple sclerosis (MS) patients. These studies not only support the possible effectiveness of anticonvulsants, but also compel further clinical trials with serotonin–norepinephrine reuptake inhibitors, the immunosuppressant drug rapamycin, or drugs which interfere with glutamatergic neurotransmission. Future behavioral studies in EAE models are essential toward a new pharmacotherapy of multiple sclerosis pain.Keywords
This publication has 138 references indexed in Scilit:
- A mechanism-based classification of pain in multiple sclerosisJournal of Neurology, 2012
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Mammalian Target of Rapamycin Signaling in the Spinal Cord Is Required for Neuronal Plasticity and Behavioral Hypersensitivity Associated With Neuropathy in the RatThe Journal of Pain, 2010
- Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disordersNeuroscience, 2010
- Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammationNeuroscience, 2010
- Neuropathogenesis of Theiler’s Murine Encephalomyelitis Virus Infection, An Animal Model for Multiple SclerosisJournal of Neuroimmune Pharmacology, 2009
- Autoimmune T cell responses in the central nervous systemNature Reviews Immunology, 2009
- Endothelial NOS‐deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitisGlia, 2009
- Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosisBrain Research, 2008
- mTOR at the crossroads of T cell proliferation and toleranceSeminars in Immunology, 2007